바로가기메뉴

본문 바로가기 주메뉴 바로가기

ACOMS+ 및 학술지 리포지터리 설명회

  • 한국과학기술정보연구원(KISTI) 서울분원 대회의실(별관 3층)
  • 2024년 07월 03일(수) 13:30
 

Immune Evasion of G-CSF and GM-CSF in Lung Cancer

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2024, v.87 no.1, pp.22-30
https://doi.org/10.4046/trd.2023.0037
Chae Uk Chung, M.D., Ph.D. (Chungnam National University Hospital)
Yeonhee Park, M.D., Ph.D. (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Daejeon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Daejeon,)
  • 다운로드 수
  • 조회수

Abstract

Tumor immune evasion is a complex process that involves various mechanisms, suchas antigen recognition restriction, immune system suppression, and T cell exhaustion. The tumor microenvironment contains various immune cells involved in immune evasion. Recent studies have demonstrated that granulocyte colony-stimulating factor(G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF) induce immuneevasion in lung cancer by modulating neutrophils and myeloid-derived suppressorcells. Here we describe the origin and function of G-CSF and GM-CSF, particularlytheir role in immune evasion in lung cancer. In addition, their effects on programmeddeath-ligand 1 expression and clinical implications are discussed.

keywords
Granulocyte Colony-Stimulating Factor, Granulocyte-Macrophage Colony- Stimulating Factor, Neutrophils, Myeloid-Derived Suppressor Cell, Programmed Death-Ligand 1, Immune Evasion

Tuberculosis & Respiratory Diseases